Studies show LHRH analogs can inhibit tumor growth by reducing sex hormone levels [101], induce apoptosis in LHRH-receptor-positive cancer cells and be effective as part of combination therapies (e.g., with chemotherapy or targeted agents) [101]. Here, GNRH1 is linked to neoplasm.